Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Email this article to a Colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Articles & Searches Download to citation manager Citing Articles via HighWire Citing Articles via Google Scholar Articles by Huckans, M. S. Articles by Hauser, P. Search for Related Content PubMed Citation Articles by Huckans, M. S. Articles by Hauser, P. Dual Diagnosis Patients Quality of Care, Practice Guidelines Other Health Services Issues Schizophrenia Spectrum Disorders

Management of Hepatitis C Disease Among VA Patients With Schizophrenia and Substance Use Disorders

OBJECTIVE: Rates of hepatitis C (HCV) infection, testing, and treatment were compared among patients with schizophrenia, a substance use disorder, or co-occurring schizophrenia or schizoaffective disorder and a substance use disorder and a control group. METHODS: Information about 293,445 patients of the Northwest Veterans Healthcare Administration was obtained. RESULTS: The substance use disorder group constituted 13.6 percent of the sample; the schizophrenia group, 1.6 percent; and the co-occurring-disorders group, 1.4 percent. Respectively, these groups were approximately four, two, and six times as likely as the control group to receive HCV testing and about seven, two, and eight times as likely to be infected. The rate of interferon (IFN) therapy was significantly lower for the substance use group and the group with co-occurring disorders. However, the magnitude of the differences was not substantial, suggesting that these high-risk groups were not excluded from IFN therapy.

This article has been cited by other articles:

				P. Hauser, B. J. Morasco, A. Linke, D. Bjornson, S. Ruimy, A. Matthews, A. Rifai, D. W. Indest, and J. M. Loftis Antiviral Completion Rates and Sustained Viral Response in Hepatitis C Patients With and Without Preexisting Major Depressive Disorder Psychosomatics, September 1, 2009; 50(5): 500 - 505. [Abstract] [Full Text] [PDF]

				S. Himelhoch, J. F. McCarthy, D. Ganoczy, D. Medoff, A. Kilbourne, R. Goldberg, L. Dixon, and F. C. Blow Understanding Associations Between Serious Mental Illness and Hepatitis C Virus Among Veterans: A National Multivariate Analysis Psychosomatics, January 1, 2009; 50(1): 30 - 37. [Abstract] [Full Text] [PDF]

				M. Huckans, A. Mitchell, S. Ruimy, J. Loftis, and P. Hauser Antiviral Therapy Completion and Response Rates Among Hepatitis C Patients With and Without Schizophrenia Schizophr Bull, June 17, 2008; (2008) sbn065v1. [Abstract] [Full Text] [PDF]

				O. Freudenreich, R. T. Gandhi, J. P. Walsh, D. C. Henderson, and D. C. Goff Hepatitis C in Schizophrenia: Screening Experience in a Community-Dwelling Clozapine Cohort Psychosomatics, October 1, 2007; 48(5): 405 - 411. [Abstract] [Full Text] [PDF]

Get information about faster international access.

Privacy Policy

Copyright © 2006 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us